28 C
Mumbai
Thursday, July 27, 2017

Anthem says may exit more individual markets over Obamacare funding

(Reuters) - Anthem Inc said it may exit more individual Obamacare markets as the future of the national healthcare law and the government subsidies...

McKesson shareholders vote against executive pay structure

(Reuters) - McKesson Corp shareholders voted against the company's executive pay policy, following a shareholder campaign that criticized the drug wholesaler for its role...

Red Cross urges West, Saudi-led coalition to resolve Yemen crisis

GENEVA (Reuters) - Western and regional powers must use their influence on Yemen's warring parties to end a two-year conflict that has exacerbated a...

Obamacare repeal battle back on the Senate floor

WASHINGTON (Reuters) - After a months-long struggle, Republicans have succeeded in bringing Obamacare repeal legislation, a centerpiece of their 2016 election campaigns, to a...

GlaxoSmithKline’s new boss streamlines R&D, axes slew of drugs

LONDON (Reuters) - GlaxoSmithKline's new chief executive announced plans on Wednesday to narrow the focus of the group's drug research by ditching more than...

Dynavax hepatitis B vaccine works; raises safety issues: FDA

(Reuters) - Dynavax Technologies Corp's experimental hepatitis B vaccine is effective, but there were more deaths and serious cardiac events in patients given the...

Anthem may exit more individual markets over Obamacare funding

(Reuters) - Anthem Inc said it may leave more individual Obamacare markets due to uncertainty about the potential repeal of the healthcare law and...

Drugmaker GSK calls for at least two years’ Brexit transition

LONDON (Reuters) - Britain's pharmaceutical industry needs at least two years' transition to cope with the impact of the country leaving the European Union,...

Cochlear unveils hearing implants that work directly with Apple’s iPhone

(Reuters) - Cochlear Ltd said Wednesday it can now stream audio directly from Apple Inc's iPhone, iPad and iPod to the microchips in its...

More deaths with Dynavax vaccine but overall rate low: FDA

(Reuters) - There were more deaths in patients taking Dynavax Technologies Corp's experimental hepatitis B vaccine than those taking a rival product, but the...
- Advertisement -

LATEST NEWS

MUST READ